These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24452067)

  • 21. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
    Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
    J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
    Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
    J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of Bayesian Area Under the Concentration-Time Curve-Based Pharmacokinetic Dosing Based on a One-Compartment Model and Trough-Only Monitoring for Vancomycin.
    Salehpour N; Riley LD; Gonzales MJ; Kobic E; Nix DE
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0017223. PubMed ID: 37133362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trough-guided Versus AUC/MIC-Guided Vancomycin Monitoring: A Cost Analysis.
    Morales Junior R; Tiguman GMB; D'Amaro Juodinis V; Santos ICPF; Leite FS; Vercelino JG; de Lima BD; Barbosa LMG
    Clin Ther; 2022 Sep; 44(9):e91-e96. PubMed ID: 36031477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC
    Issaranggoon Na Ayuthaya S; Katip W; Oberdorfer P; Lucksiri A
    Int J Infect Dis; 2020 Mar; 92():151-159. PubMed ID: 31935538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
    Aubron C; Corallo CE; Nunn MO; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Oct; 45(10):1193-8. PubMed ID: 21896920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
    Aljutayli A; Thirion DJG; Bonnefois G; Nekka F
    Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
    Hsu AJ; Hamdy RF; Huang Y; Olson JA; Ghobrial S; Gerber JS; Hersh AL; Tamma PD
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):338-341. PubMed ID: 28992126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of a vancomycin loading dose in children.
    Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AUC- vs. Trough-Guided Monitoring of Vancomycin in Infants.
    Alsultan A; Abouelkheir M; Albassam A; Alharbi E; Assiri A; Alqahtani S
    Indian J Pediatr; 2020 May; 87(5):359-364. PubMed ID: 31984471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
    Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
    J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R; So H; Seo E; Kim M; Lee J
    PLoS One; 2021; 16(4):e0247714. PubMed ID: 33793589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
    Stockmann C; Olson J; Rashid J; Lubsch L; Young DC; Hersh AL; Frymoyer A; Ampofo K; Liu X; Wang Y; Sherwin CMT; Zobell JT
    J Clin Pharmacol; 2019 Feb; 59(2):198-205. PubMed ID: 30371946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.
    Neely MN; Kato L; Youn G; Kraler L; Bayard D; van Guilder M; Schumitzky A; Yamada W; Jones B; Minejima E
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.